PharmaCyte Biotech Inc (PMCB)
NASDAQ
News
Market Data
Customized watchlists with full streaming quotes from leading exchanges, such as NASDAQ, NYSE, AMEX, OTC Markets Small-Cap, LSE and more.
| Year End April 29 2024 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Return on Assets (%) | -56.157 | -90.57 | -66.699 | -64.056 | -52.332 | -8.649 | -5.267 | -25.885 |
| Return on Equity (%) | -60.839 | -98.571 | -75.252 | -75.565 | -60.35 | -8.776 | -5.308 | -34.358 |
| Return on Invested Capital (%) | -77.59 | -130.529 | -107.176 | -109.078 | -83.711 | -9.401 | -8.097 | -12.696 |
| Operating Margin (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Net Profit Margin (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Book Value Per Share | 0.005 | 0.002 | 0.001 | 0.001 | 0.31 | 2.954 | 2.587 | 2.236 |
| Earnings Per Share | -0.005 | -0.007 | -0.003 | -0.002 | -0.351 | -0.145 | -0.162 | -1.015 |
| Cash Per Share | 0.004 | 0.001 | N/A | 0.001 | 0.218 | 2.921 | 2.546 | 2.955 |
| Working Capital Per Share | 0.003 | 0.001 | N/A | N/A | 0.153 | 2.9 | 2.528 | 2.534 |
| Operating Profit Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| EBIT Per Share | -0.005 | -0.007 | -0.003 | -0.002 | -0.351 | -0.145 | -0.162 | 0.02 |
| EBITDA Per Share | -0.005 | -0.007 | -0.003 | -0.002 | -0.351 | -0.145 | -0.162 | 0.02 |
| Free Cash Flow Per Share | -0.005 | -0.007 | -0.003 | -0.002 | -0.351 | -0.145 | -0.162 | -1.015 |
| Year End April 29 2024 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|
| Current Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Quick Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Inventory Turnover (Days) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Shares Outstanding | 905.35M | 1.01B | 1.19B | 1.64B | 1.59M | 20.72M | N/A | N/A |
| Year End April 29 2024 | Jul 2022 | Oct 2022 | Jan 2023 | Apr 2023 | Jul 2023 | Oct 2023 | Jan 2024 | Apr 2024 |
|---|---|---|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Shares Outstanding | 20.75M | 19.53M | 18.21M | N/A | 8.78M | N/A | N/A | N/A |
| Return on Assets (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Return on Equity (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Return on Invested Capital (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Operating Margin (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Net Profit Margin (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Sales Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Book Value Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Earnings Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Cash Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Working Capital Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Operating Profit Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| EBIT Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| EBITDA Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Free Cash Flow Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Current Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Quick Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Inventory Turnover (Days) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Market Cap | 12.71M |
| Price to Earnings Ratio | -0.71 |
| Price to Sales Ratio | 0 |
| Price to Cash Ratio | 0.24 |
| Price to Book Ratio | 0.31 |
| Dividend Yield | - |
| Shares Outstanding | 7.71M |
| Average Volume (1 week) | 13.71k |
| Average Volume (1 Month) | 15.4k |
| 52 Week Change | -33.19% |
| 52 Week High | 2.629 |
| 52 Week Low | 1.39 |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
